Diabetes - Continuous Subcutaneous Insulin Infusion

Advances in technology and knowledge of diabetes management have offered enhanced options for individuals with diabetes to optimize their glycemic control (1). Coupled with self-management education, intensive diabetes management, including multiple daily injections (MDI) or continuous subcutaneous insulin infusion (CSII), is associated with a reduced risk of diabetes microvascular and macrovascular complications (1-3).

 

Insulin dosing strategies should be individualized based on the